Integrated Diagnostics Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Integrated Diagnostics Holdings generated cash of $543,663,000, which is more than the previous year. Cash used in financing activities reached the amount of -$330,461,000 last year. Net change in cash is therefore $25,741,000.
Cash Flow
| 2014 | 301.58M | -70.29M | -234.01M |
|---|---|---|---|
| 2015 | 189.86M | -42.41M | -12.76M |
| 2016 | 398.65M | -137.52M | -118.20M |
| 2017 | 403.07M | -33.89M | -370.82M |
| 2018 | 556.30M | -465.61M | -358.72M |
| 2019 | 697.41M | -136.35M | -548.73M |
| 2020 | 882.51M | -124.26M | -563.53M |
| 2021 | 2.26B | -1.32B | -647.14M |
| 2022 | 208.72M | 990.11M | -1.61B |
| 2023 | 543.66M | -243.94M | -330.46M |
IDHC.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 648.51M | 891.45M | 600.13M | 408.89M | 412.60M | 685.21M | 683.72M | 387.71M | 252.11M | 262.58M |
Operating activities | ||||||||||
Net income | 737.35M | 853.64M | 2.23B | 969.08M | 758.14M | 717.35M | 558.43M | 388.53M | 274.49M | 241.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 401.23M | 317.34M | 238.64M | 185.36M | 153.47M | 77.38M | 61.92M | 44.73M | 36.19M | 115.58M |
Stock-based compensation expense | -7.09M | -7.59M | 0 | 0 | -6.39M | 0 | 0 | 0 | 1.03M | 0 |
| Deferred income tax benefit | -7.09M | -7.59M | 0 | 0 | -6.39M | 0 | 0 | 0 | 1.03M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -198.07M | -53.44M | -106.45M | -140.56M | -78.16M | -118.04M | -43.57M | -30.43M | -36.35M | -3.37M |
Inventories | -104.90M | -30.15M | -127.64M | -17.12M | 4.93M | -21.14M | -18.22M | -17.38M | 1.68M | -7.44M |
Accounts payable | 198.07M | 53.44M | 106.45M | 140.56M | 78.16M | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 543.66M | 208.72M | 2.26B | 882.51M | 697.41M | 556.30M | 403.07M | 398.65M | 189.86M | 301.58M |
Investing activities | ||||||||||
Purchases Of Investments | -243.56M | -1.27B | -1.59B | -112.11M | -282.78M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -323.43M | -308.83M | -263.73M | -126.01M | -217.99M | -331.55M | -157.34M | -48.53M | -54.89M | -76.08M |
Acquisitions Net | 0 | 0 | 10.35M | 48.86M | 46.95M | 20.51M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -243.94M | 990.11M | -1.32B | -124.26M | -136.35M | -465.61M | -33.89M | -137.52M | -42.41M | -70.29M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | -1.41B | -478.74M | -450.73M | -450.50M | -434.95M | -376.74M | -88.56M | -6.46M | -229.71M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -244.41M | -82.48M | -25.41M | -25.41M | -20.13M | -20.51M | 53M | -8.92M | -1.75M | -448.06K |
Cash used in financing activities | -330.46M | -1.61B | -647.14M | -563.53M | -548.73M | -358.72M | -370.82M | -118.20M | -12.76M | -234.01M |
Net Change In Cash | 25.74M | -242.93M | 291.32M | 191.23M | -3.71M | -272.60M | 1.49M | 296.00M | 135.60M | -10.47M |
Cash at end of period | 674.25M | 648.51M | 891.45M | 600.13M | 408.89M | 412.60M | 685.21M | 683.72M | 387.71M | 252.10M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |